About the Company
We do not have any company description for AzurRx BioPharma Inc at the moment.
Exchange
NASDAQ
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $AZRX News
Future Arca BioPharma ops ‘highly dependent’ on Oruka merger
The future of Arca Biopharma is “highly dependent” on the successful consummation of its merger with Oruka Therapeutics Inc.
First Wave BioPharma Inc (FWBI)
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
GT Biopharma Inc GTBP
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Q4 2023 Cue Biopharma Inc Earnings Call
Stephen Willey; Analyst; Stifel Financial Corp. Reni Benjamin; Analyst; JMP Securities LLC Operator Greetings, and welcome to the Cue Biopharma Investor Update Call. (Operator Instructions ...
ArriVent BioPharma, Inc. (AVBP)
NEWTON SQUARE, Pa., April 22, 2024 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc., a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical ...
ABVC BioPharma Inc
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Aytu BioPharma Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Cue Biopharma Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
SBFM Sunshine Biopharma, Inc.
Sunshine Biopharma, Inc., a pharmaceutical company, focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals. The company is ...
Aytu BioPharma, Inc. Common Stock (AYTU)
Nasdaq provides press releases highlighting valuable information sent out by companies. Here you can find the company’s latest financial figures, contact information, and source version of the ...
First Wave BioPharma Inc (FWBI)
First Wave BioPharma, Inc. ("First Wave BioPharma" or the “Company”) (FWBI), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic ...
First Wave BioPharma Inc (FWBI)
In a recent move, James Sapirstein, the Chairman and CEO of First Wave BioPharma, Inc. (NASDAQ:FWBI), sold a total of 1,887 shares of the company's common stock. The transaction, ...
Loading the latest forecasts...